Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. HOOD
9. DFTX
10. IBM

Go back to Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Tops Q4 EPS by 36c, Revenues Miss

February 27, 2020 6:43 AM EST

SAGE Therapeutics (NASDAQ: SAGE) reported Q4 EPS of ($3.25), $0.36 better than the analyst estimate of ($3.61). Revenue for the quarter came in at $1.96 million versus the consensus estimate of $3.68 million.

The progress we made in 2019 across our depression, neuropsych and neurology franchises supports our... More